CISF takes over security of Covaxin manufacturer Bharat Biotech's Hyderabad campus

Credit: IndiaTimes- Published on June 14, 2021

You are here


💡 newsR Knowledge: Other News Mentions

Bharat Biotech

Indian biotechnology company and vaccine manufacturer
After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
Credit: IndiaTimes - Published 3 days ago

Credit: IndiaTimes - Published 4 days ago

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
Credit: IndiaTimes - Published 4 days ago

Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation..
Credit: IndiaTimes - Published 1 week ago


Covaxin

Vaccine against COVID-19
An expert panel of India's central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a..
Credit: IndiaTimes - Published 2 days ago

In view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
Credit: DNA - Published 1 week ago


Related news from verified sources

The Hyderabad-based COVID vaccine manufacturer also said that it will publish the phase 3 trial data in July and after that, it will be applying for the full...
on June 9, 2021 • Zee News

You might like